279 related articles for article (PubMed ID: 26052670)
1. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.
Pappas SS; Darr K; Holley SM; Cepeda C; Mabrouk OS; Wong JM; LeWitt TM; Paudel R; Houlden H; Kennedy RT; Levine MS; Dauer WT
Elife; 2015 Jun; 4():e08352. PubMed ID: 26052670
[TBL] [Abstract][Full Text] [Related]
2. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
[TBL] [Abstract][Full Text] [Related]
3. A cell autonomous torsinA requirement for cholinergic neuron survival and motor control.
Pappas SS; Li J; LeWitt TM; Kim JK; Monani UR; Dauer WT
Elife; 2018 Aug; 7():. PubMed ID: 30117805
[TBL] [Abstract][Full Text] [Related]
4. Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia.
DeSimone JC; Pappas SS; Febo M; Burciu RG; Shukla P; Colon-Perez LM; Dauer WT; Vaillancourt DE
Neurobiol Dis; 2017 Oct; 106():124-132. PubMed ID: 28673740
[TBL] [Abstract][Full Text] [Related]
5. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.
Downs AM; Fan X; Kadakia RF; Donsante Y; Jinnah HA; Hess EJ
Neurobiol Dis; 2021 Jul; 155():105369. PubMed ID: 33894367
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
[TBL] [Abstract][Full Text] [Related]
7. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.
Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A
Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103
[TBL] [Abstract][Full Text] [Related]
8. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.
Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A
Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the cholinergic system and motor deficits in cholinergic neuron-specific Dyt1 knockout mice.
Liu Y; Xing H; Sheng W; Singh KN; Korkmaz AG; Comeau C; Anika M; Ernst A; Yokoi F; Vaillancourt DE; Frazier CJ; Li Y
Neurobiol Dis; 2021 Jul; 154():105342. PubMed ID: 33757902
[TBL] [Abstract][Full Text] [Related]
10. Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.
Crevier-Sorbo G; Rymar VV; Crevier-Sorbo R; Sadikot AF
Acta Neuropathol Commun; 2020 Feb; 8(1):14. PubMed ID: 32033588
[TBL] [Abstract][Full Text] [Related]
11. TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.
Liang CC; Tanabe LM; Jou S; Chi F; Dauer WT
J Clin Invest; 2014 Jul; 124(7):3080-92. PubMed ID: 24937429
[TBL] [Abstract][Full Text] [Related]
12. In vivo optogenetic inhibition of striatal parvalbumin-reactive interneurons induced genotype-specific changes in neuronal activity without dystonic signs in male DYT1 knock-in mice.
Schulz A; Richter F; Richter A
J Neurosci Res; 2023 Apr; 101(4):448-463. PubMed ID: 36546658
[TBL] [Abstract][Full Text] [Related]
13. Optogenetic augmentation of the hypercholinergic endophenotype in DYT1 knock-in mice induced erratic hyperactive movements but not dystonia.
Richter F; Bauer A; Perl S; Schulz A; Richter A
EBioMedicine; 2019 Mar; 41():649-658. PubMed ID: 30819512
[TBL] [Abstract][Full Text] [Related]
14. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
[TBL] [Abstract][Full Text] [Related]
15. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
Ip CW; Isaias IU; Kusche-Tekin BB; Klein D; Groh J; O'Leary A; Knorr S; Higuchi T; Koprich JB; Brotchie JM; Toyka KV; Reif A; Volkmann J
Acta Neuropathol Commun; 2016 Oct; 4(1):108. PubMed ID: 27716431
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific effects of Dyt1 knock-out on sensory processing, network-level connectivity, and motor deficits.
Wilkes BJ; DeSimone JC; Liu Y; Chu WT; Coombes SA; Li Y; Vaillancourt DE
Exp Neurol; 2021 Sep; 343():113783. PubMed ID: 34119482
[TBL] [Abstract][Full Text] [Related]
17. Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia.
Song CH; Bernhard D; Bolarinwa C; Hess EJ; Smith Y; Jinnah HA
Neurobiol Dis; 2013 Jun; 54():362-71. PubMed ID: 23336980
[TBL] [Abstract][Full Text] [Related]
18. Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model.
Yellajoshyula D; Opeyemi S; Dauer WT; Pappas SS
Dystonia; 2022; 1():. PubMed ID: 36874764
[TBL] [Abstract][Full Text] [Related]
19. Minimal Change in the cytoplasmic calcium dynamics in striatal GABAergic neurons of a DYT1 dystonia knock-in mouse model.
Iwabuchi S; Koh JY; Wang K; Ho KW; Harata NC
PLoS One; 2013; 8(11):e80793. PubMed ID: 24260480
[TBL] [Abstract][Full Text] [Related]
20. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.
Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG
J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
